These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 14696969)

  • 1. Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis.
    Zalavras C; Shah S; Birnbaum MJ; Frenkel B
    Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):221-35. PubMed ID: 14696969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteogenic growth peptide effects on primary human osteoblast cultures: potential relevance for the treatment of glucocorticoid-induced osteoporosis.
    Spreafico A; Frediani B; Capperucci C; Leonini A; Gambera D; Ferrata P; Rosini S; Di Stefano A; Galeazzi M; Marcolongo R
    J Cell Biochem; 2006 Jul; 98(4):1007-20. PubMed ID: 16795077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid-induced osteoporosis: an osteoblastic disease.
    Migliaccio S; Brama M; Fornari R; Greco EA; Spera G; Malavolta N
    Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):5-10. PubMed ID: 18180599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of apoptosis in osteoporosis induced by glucocorticoids.
    Spreafico A; Frediani B; Francucci CM; Capperucci C; Chellini F; Galeazzi M
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):22-7. PubMed ID: 18791347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glucocorticoids and osteoporosis].
    Zikán V
    Vnitr Lek; 2007; 53(7-8):831-40. PubMed ID: 17915428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histomorphometric analysis of glucocorticoid-induced osteoporosis.
    Dalle Carbonare L; Bertoldo F; Valenti MT; Zenari S; Zanatta M; Sella S; Giannini S; Cascio VL
    Micron; 2005; 36(7-8):645-52. PubMed ID: 16243531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of corticosteroids on bone metabolism: a review.
    Mitra R
    PM R; 2011 May; 3(5):466-71; quiz 471. PubMed ID: 21570035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor.
    Rauch A; Seitz S; Baschant U; Schilling AF; Illing A; Stride B; Kirilov M; Mandic V; Takacz A; Schmidt-Ullrich R; Ostermay S; Schinke T; Spanbroek R; Zaiss MM; Angel PE; Lerner UH; David JP; Reichardt HM; Amling M; Schütz G; Tuckermann JP
    Cell Metab; 2010 Jun; 11(6):517-31. PubMed ID: 20519123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis.
    van Staa TP
    Calcif Tissue Int; 2006 Sep; 79(3):129-37. PubMed ID: 16969593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo.
    Buttgereit F; Zhou H; Kalak R; Gaber T; Spies CM; Huscher D; Straub RH; Modzelewski J; Dunstan CR; Seibel MJ
    Arthritis Rheum; 2009 Jul; 60(7):1998-2007. PubMed ID: 19565501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteocyte biology: its implications for osteoporosis.
    Bonewald LF
    J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):101-4. PubMed ID: 15615083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio.
    Wiren KM; Toombs AR; Semirale AA; Zhang X
    Bone; 2006 May; 38(5):637-51. PubMed ID: 16413235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylaxis of glucocorticoid-induced osteoporosis].
    Tanaka Y
    Clin Calcium; 2006 Nov; 16(11):1858-65. PubMed ID: 17079853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of genistein aglycone on the development of osteonecrosis of the femoral head and secondary osteoporosis induced by methylprednisolone in rats.
    Bitto A; Polito F; Burnett B; Levy R; Di Stefano V; Armbruster MA; Marini H; Minutoli L; Altavilla D; Squadrito F
    J Endocrinol; 2009 Jun; 201(3):321-8. PubMed ID: 19332450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip.
    Weinstein RS; Nicholas RW; Manolagas SC
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2907-12. PubMed ID: 10946902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Action of glucocorticoid on bone-forming and bone-resorbing cells].
    Hakeda Y
    Clin Calcium; 2006 Nov; 16(11):1817-22. PubMed ID: 17079848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis.
    Sorocéanu MA; Miao D; Bai XY; Su H; Goltzman D; Karaplis AC
    J Endocrinol; 2004 Oct; 183(1):203-16. PubMed ID: 15525588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of osteonecrosis.
    Jones LC; Hungerford DS
    Instr Course Lect; 2007; 56():179-96. PubMed ID: 17472306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secondary osteoporosis. Pathogenesis of glucocorticoid-induced osteoporosis].
    Takayanagi R
    Clin Calcium; 2007 Feb; 17(2):270-4. PubMed ID: 17272886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.